Most patients do not experience significant weight loss in the first week, as your body needs time to adjust, and the dosage is increased gradually to help minimize side effects
If you still have questions or just want to get started complete the new patient form at the top of the page or by clicking here
Clinical Study Results and Key Findings Aggregated results across clinical trials confirm that retatrutide produces profound weight loss and metabolic improvements with a manageable safety profile
Average discount is 23%
Saxenda liraglutide injection, solution, DailyMed (2025) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) First generic GLP-1 indicated for weight loss, Teva Pharmaceuticals Investor Relations (2025) Liraglutide injection, solution, DailyMed (2025) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, Food and Drug Administration (2024) Bioequivalence and interchangeability of generic medications, Merck Manual Consumer Version (2025) Liraglutide injection, DailyMed (2025) Medicare coverage of GLP-1 drugs, Library of Congress (2024) FDA drug shortages, Food and Drug Administration (2025) Compounding when drugs are on FDAs Drug Shortages List, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polipeptide ans glucagon-like peptide -1 (7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations